Dose daily

Pfizer’s Strategic Exit from BioNTech Post Covid Vaccine Windfall

By: Dose Daily News Bureau

Date:

Share post:

Previous article
MoHFW Officially Notifies the 2025 Recruitment Rules for Drug Inspector Posts Under CDSCO
Next article
UGC’s Yuvamanthan Initiative – Advisory Issued for Strict Implementation of the POSH Act
Dose Daily News Bureau
Dose Daily News Bureauhttps://dosedailynews.com/

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Breaking News

Johnson & Johnson to acquire Firefly Bio to advance novel cancer treatment

Johnson & Johnson  announced that it has entered into a definitive agreement to acquire Firefly Bio, Inc., a...
Breaking News

Emergency Price Adjustment Approved for Critical Cancer Drugs Amid Raw Material Crisis

In a decisive move to counter critical domestic medicine shortages caused by global macroeconomic headwinds, the Department of...
Breaking News

India Targets 100 New Biologic Medicines by 2047 Under Biopharma SHAKTI

At the landmark 2nd Pharma Summit & Awards 2026 organized by the Associated Chambers of Commerce and Industry...
Breaking News

Investors Show Strong Interest in Hexagon Nutrition IPO, Bids Reach 54 Times

Hexagon Nutrition Limited, a leading research-driven nutrition company, concluded its Initial Public Offering (IPO) with resounding success, achieving...